StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
September 8, 2026 5:03 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $56.00 price target on Boston Scientific (NYSE: BSX).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
